Expertise in
1
conditions

Stephen R. Macfarlane

Malvern, VIC, AU 
Expertise in
1
conditions
Malvern, VIC, AU 
OverviewLocationsClinical Research

Overview

Stephen Macfarlane practices in Malvern, Australia. Mr. Macfarlane is highly rated in 1 condition, according to our data. His top areas of expertise are Dementia, Alzheimer's Disease, Vascular Dementia, and Frontotemporal Dementia.

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Malvern, VIC, Australia
Other Locations
Melbourne, VIC, Australia
Clayton, VIC, Australia
Wollongong, NSW, Australia
Sydney, NSW, Australia
VIC, Australia
Wembley, WA, Australia
Delmont, TAS, Australia
Caulfield, VIC, Australia
Greenwich, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Drug
Study Drug: LY3372689
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2
View 2 Less Clinical Trials

40 Total Publications

Research Letters: Delivering the new standard for psychotropic medicines on information transfers at transitions of care: A qualitative study of stakeholder priorities.
Research Letters: Delivering the new standard for psychotropic medicines on information transfers at transitions of care: A qualitative study of stakeholder priorities.
Journal: The Australian and New Zealand journal of psychiatry
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Macfarlane's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile